HGF/c-MET pathway in cancer: from molecular characterization to clinical evidence

J Fu, X Su, Z Li, L Deng, X Liu, X Feng, J Peng - Oncogene, 2021 - nature.com
This review provides a comprehensive landscape of HGF/c-MET (hepatocyte growth factor
(HGF)/mesenchymal–epithelial transition factor (c-MET)) signaling pathway in cancers. First …

HGF/MET pathway aberrations as diagnostic, prognostic, and predictive biomarkers in human cancers

F Moosavi, E Giovannetti, L Saso… - Critical reviews in clinical …, 2019 - Taylor & Francis
Cancer is a major cause of death worldwide. MET tyrosine kinase receptor [MET, c-MET,
hepatocyte growth factor (HGF) receptor] pathway activation is associated with the …

[HTML][HTML] The oncogenic role of Jagged1/Notch signaling in cancer

M Xiu, Y Liu, B Kuang - Biomedicine & Pharmacotherapy, 2020 - Elsevier
Aberrant activation of Notch signaling plays an oncogenic role in cancer development.
Jagged1 (JAG1) is an important Notch ligand that triggers Notch signaling through cell-cell …

A review: hippo signaling pathway promotes tumor invasion and metastasis by regulating target gene expression

HL Li, QY Li, MJ Jin, CF Lu, ZY Mu, WY Xu… - Journal of Cancer …, 2021 - Springer
Abstract Background The Hippo pathway is widely considered to inhibit cell growth and play
an important role in regulating the size of organs. However, recent studies have shown that …

MET Inhibitors for the Treatment of Gastric Cancer: What's Their Potential?

H El Darsa, R El Sayed… - Journal of experimental …, 2020 - Taylor & Francis
Gastric cancer remains a disease with a dismal prognosis. Extensive efforts to find
targetable disease drivers in gastric cancer were implemented to improve patient outcomes …

[HTML][HTML] Mesenchymal stromal cells induce distinct myeloid-derived suppressor cells in inflammation

HJ Lee, JH Ko, HJ Kim, HJ Jeong, JY Oh - JCI insight, 2020 - ncbi.nlm.nih.gov
Mesenchymal stem/stromal cells (MSCs) regulate immunity through myeloid-derived
suppressor cells (MDSCs), which are a heterogeneous population of immature myeloid cells …

[HTML][HTML] Lidocaine suppresses the malignant behavior of gastric cancer cells via the c‑Met/c‑Src pathway

W Zeng, ZT Xing, MY Tan… - Experimental and …, 2021 - spandidos-publications.com
The present study was designed to investigate the role and mechanism of action behind the
action of lidocaine in gastric cancer cells. Lidocaine was tested for its potential role in …

[HTML][HTML] Notch signaling pathway in cancer: from mechanistic insights to targeted therapies

Q Shi, C Xue, Y Zeng, X Yuan, Q Chu, S Jiang… - … and Targeted Therapy, 2024 - nature.com
Notch signaling, renowned for its role in regulating cell fate, organ development, and tissue
homeostasis across metazoans, is highly conserved throughout evolution. The Notch …

[HTML][HTML] Cancer signaling pathways with a therapeutic approach: An overview in epigenetic regulations of cancer stem cells

AA Samadani, SE Norollahi, A Rashidy-Pour… - Biomedicine & …, 2018 - Elsevier
One of the most important issues in cancer progression is caner stem cells (CSCs) which
have illustrated that the bulk tumors can arise from a special combination of cells …

Nanoscale mapping of EGFR and c-MET protein environments on lung cancer cell surfaces via therapeutic antibody photocatalyst conjugates

T Reyes-Robles, AK Olow, TJ Bechtel… - ACS Chemical …, 2022 - ACS Publications
Receptor tyrosine kinases are involved in essential signaling roles that impact cell growth,
differentiation, and proliferation. The overexpression or mutation of these proteins can lead …